A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma

Annals of Surgery

Volumn 249, Issue 2, 2009, Pages 195-202

  Zhou, Wei Ping ^a   Lai, Eric C H ^b   Li, Ai Jun ^a   Fu, Si Yuan ^a   Zhou, Jian Ping ^a   Pan, Ze Ya ^a   Lau, Wan Yee ^b   Wu, Meng Chao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ALPHA GLOBULIN; BILIRUBIN; CISPLATIN; FLUOROURACIL; IODINATED POPPYSEED OIL; MITOMYCIN C; PREALBUMIN;

ADULT; ARTICLE; BILE LEAKAGE; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EMULSION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; MORTALITY; OPERATION DURATION; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TRANSARTERIAL CHEMOEMBOLIZATION; TUMOR NECROSIS; TUMOR VOLUME; VIRUS CARRIER; WOUND INFECTION; ADJUVANT THERAPY; LIVER RESECTION; LIVER TUMOR; MIDDLE AGED; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 61549106905     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181961c16     Document Type: Article

References (22)

1. Lau WY. Management of hepatocellular carcinoma. J R Coll Surg Edinb. 2002;47:389-399.
2. Lai EC, Lau WY. The continuing challenge of hepatic cancer in Asia. Surgeon. 2005;3:210-215.
3. Lau WY, Leung TW, Yu SC, et al. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg. 2003;237:171-179.
4. Lau WY. Primary hepatocellular carcinoma. In: Blumgart LH, Fong Y, eds. Surgery of The Liver and Biliary Tract. Vol. 2. London: WB Saunders; 2000:1423-1450.
5. Belghiti J. Surgical treatment. In: Lau WY, ed. Hepatocellular Carcinoma. Singapore: World Scientific Publishing Co Ltd; 2008:387-408.
6. Lau WY, Lai EC. Neoadjuvant/Adjuvant/Chemoprevention therapy and Tumor Downstaging. In: Lau WY, ed. Hepatocellular Carcinoma. Singapore: World Scientific Publishing Co Ltd; 2008:709-737.
7. Lau WY, Lai EC, Leung TW, et al. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival. Ann Surg. 2008;247:43-48.
8. Chan ES, Chow PK, Tai B, et al. Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma. Cochrane Database Syst Rev. 2000: CD001199.
9. Schwartz JD, Schwartz M, Mandeli J, et al. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol. 2002;3:593- 603.
10. Lau WY, Yu SC, Lai EC, et al. Transarterial chemoembolization for hepatocellular carcinoma. J Am Coll Surg. 2006;202:155-168.
11. Zhang Z, Liu Q, He J, et al. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer. 2000;89:2606-2612.
12. Luo YQ, Wang Y, Chen H, et al. Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2002;1:523-526.
13. Wong IH, Yeo W, Leung T, et al. Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation. Cancer Lett. 2001;167: 183-191.
14. Wong IH, Lau WY, Leung T, et al. Hematogenous dissemination of hepato-cytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res. 1999;5:4021- 4027.
15. Wong IH, Leung T, Ho S, et al. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. 0Br J Cancer. 1997;76:628-633.
16. Sasaki A, Iwashita Y, Shibata K, et al. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. Eur J Surg Oncol. 2006;32:773-779.
17. Nagasue N, Galizia G, Kohno H, et al. Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections. Surgery. 1989;106:81-86.
18. Harada T, Matsuo K, Inoue T, et al. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg. 1996;224:4-9.
19. Sugo H, Futagawa S, Beppu T, et al. Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence. World J Surg. 2003;27:1295-1299.
20. Choi GH, Kim DH, Kang CM, et al. Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma? World J Surg. 2007;31:2370-2377.
21. Wu CC, Ho YZ, Ho WL, et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg. 1995;82:122-126.
22. Yamasaki S, Hasegawa H, Kinoshita H, et al. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res. 1996;87: 206-211.